Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 5, 2010, Pages 2241-2246

  Yoong, Pauline ^a   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bacterial pathogenesis; Immunity; MRSA; Panton valentine leukocidin

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE REPLICATION; IN VITRO STUDY; INNATE IMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; GENES, BACTERIAL; HUMANS; IMMUNITY, INNATE; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; VIRULENCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE; MUS; STAPHYLOCOCCUS AUREUS;

EID: 76649119813     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0910344107     Document Type: Article

References (39)

1. Francis JS, et al. (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100-107.
2. Gorak EJ, Yamada SM, Brown JD (1999) Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 29:797-800.
3. Herold BC, et al. (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598.
4. Naimi TS, et al. (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
5. Gillet Y, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759.
6. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-1406.
7. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR (2008) Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198:1166-1170.
8. Voyich JM, et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194:1761-1770.
9. Labandeira-Rey M, et al. (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:1130-1133.
10. Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric poreforming cytolytic toxins: Structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981-1003.
11. Finck-Barbançon V, Duportail G, Meunier O, Colin DA (1993) Pore formation by a twocomponent leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1182:275-282.
12. Hensler T, et al. (1994) Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: Protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun 62:2529-2535.
13. Begier EM, et al., Connecticut Bioterrorism Field Epidemiology Response Team (2004) A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 39:1446-1453.
14. Ford CW, Hamel JC, Stapert D, Yancey RJ (1989) Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J Med Microbiol 28:259-266.
15. Gauduchon V, et al. (2004) Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189:346-353.
16. Schaff UY, et al. (2008) Calcium flux in neutrophils synchronizes beta2 integrin adhesive and signaling events that guide inflammatory recruitment. Ann Biomed Eng 36:632-646.
17. Fattom A, et al. (2004) Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 23:656-663.
18. Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB (2006) Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 74:2742-2750.
19. Maira-Litrán T, Kropec A, Goldmann DA, Pier GB (2005) Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-β- (1-6)-glucosamine. Infect Immun 73: 6752-6762.
20. Cunnion KM, Lee JC, Frank MM (2001) Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 69: 6796-6803.
21. Cunnion KM, Zhang HM, Frank MM (2003) Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect Immun 71:656-662.
22. Huang SS, et al. (2008) Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis 46: 1241-1247.
23. Miller LG, et al. (2007) A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 44:483-492.
24. Nguyen DM, Mascola L, Brancoft E (2005) Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11:526-532.
25. Skiest D, et al. (2006) Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 7:361-368.
26. Brown EL, et al. (2009) Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol 16:139-141.
27. Croze M, et al. (2009) Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection. Clin Microbiol Infect 15:144-148.
28. König B, et al. (1994) Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): Generation of interleukin-8. Infect Immun 62:4831-4837.
29. Konig B, Prevost G, Piemont Y, Konig W (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171:607-613.
30. Li M, et al. (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 106:5883-5888.
31. Brown EL, et al. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15:156-164.
32. Tseng CW, et al. (2009) Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 4:e6387.
33. Liu GY, et al. (2005) Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202:209-215.
34. Green S, Rothman A (2006) Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19:429-436.
35. Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36:281-285.
36. Muller E, et al. (1993) Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun 61:551-558.
37. Arnaud M, Chastanet A, Débarbouillé M (2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC content, gram-positive bacteria. Appl Environ Microbiol 70:6887-6891.
38. Lee J (1993) Methods in Molecular Biology, ed Nickloloff JA (Humana Press Inc,Totowa, NJ), pp 209-212.
39. Foster TJ, Höök M (1998) Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6:484-488.